decreased pancreatic beta cell mass_Sox9<tm1.1Gsr>/Sox9<+>

http://metadb.riken.jp/0009114I129S4SvJaeCD1Sox9tm11GsrSox9Sox9tm11GsrSox9

decreased pancreatic beta cell mass_Sox9<tm1.1Gsr>/Sox9<+>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• SRY (sex determining region Y)-box 9
  http://metadb.riken.jp/db/mgi_rdf/MGI:98371

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Sox9<tm1.1Gsr>/Sox9<+>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Sox9<tm1.1Gsr>|Sox9<+>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S4/SvJae * CD-1

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased pancreatic beta cell mass
  http://purl.obolibrary.org/obo/MP_0009114

文献

http://purl.org/net/cito/citesAsAuthority

• Philip A. Seymour, et.al., A dosage-dependent requirement for Sox9 in pancreatic endocrine cell formation., Developmental biology, 2008, 323
  http://rdf.ncbi.nlm.nih.gov/pubmed/18723011